VITA 34 International AG: VITA 34 plans further growth in 2011 and international expansion

Sales forecast of more than 18m Euro for 2011

28-Mar-2011 - Germany

The VITA 34 International AG wants to continue its growth in the current business year 2011 and aims at increasing the revenue from approximately 17m Euro in 2010 to more than 18m Euro. It is also intended to further increase the number of storages. With 11,038 umbilical cord blood storages in the expired period under review 2010, VITA 34 has achieved the highest number of storages ever in the company's history. Furthermore, the company confirms the published preliminary figures for the business year 2010.

VITA 34 also plans to considerably improve the profitability in 2011. In 2010, the company had already increased the earnings before interest and taxes (EBIT) to 0.7m Euro from 0.2m Euro in the year before. This results in an EBIT margin of 4.4 percent. In the medium term, this margin is to be increased to a minimum of 10 percent.

The successful international sales, which account for about one third of the storages, contribute to the company's growth. The principal share is generated on the Spanish market, in which VITA 34 is represented by its subsidiary Secuvita, S. L.

Through cooperations, VITA 34 is also actively operating in Italy, Slovenia, and in Switzerland. In order to secure future potentials for growth, VITA 34 wants to develop the international business and expand in Slovakia still in 2011. This market is attractive, among other things, because of the low degree of competition and is to additionally contribute to the operating income in the medium term already.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances